BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 25234939)

  • 1. A severe case of esophageal ulcer causing a tight stricture despite long-term D-penicillamine treatment.
    Yapali S; Turan I; Ozutemiz O; Tekesin O
    Wien Klin Wochenschr; 2014 Dec; 126(23-24):789-91. PubMed ID: 25234939
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Esophageal stricture from idiopathic ulcers in an AIDS patient: a case report and review of the literature.
    Borum ML; Marks ZH
    J Clin Gastroenterol; 1999 Apr; 28(3):260-1. PubMed ID: 10192618
    [No Abstract]   [Full Text] [Related]  

  • 3. Esophageal stricture after cytomegalovirus ulcer treated with ganciclovir.
    Goodgame RW; Ross PG; Kim HS; Hook AG; Sutton FM
    J Clin Gastroenterol; 1991 Dec; 13(6):678-81. PubMed ID: 1662246
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Idiopathic esophageal ulcers in an AIDS patient resulting in a stricture.
    Borum ML; Marks ZH
    AIDS Patient Care STDS; 2000 Feb; 14(2):65-6. PubMed ID: 10743516
    [No Abstract]   [Full Text] [Related]  

  • 5. [Nephrotic syndrome after treatment with d-penicillamine in a pediatric patient with Wilson's disease].
    Farallo M; Amoruso C; Frattini C; Ardissino G; Nebbia G
    Pediatr Med Chir; 2012; 34(5):234-6. PubMed ID: 23342748
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Membranoproliferative glomerulonephritis in a patient with Wilson's disease.
    Ozçakar ZB; Ekim M; Ensari A; Kuloglu Z; Yüksel S; Acar B; Kirsaçlioglu C; Kansu A; Yalçinkaya F; Girgin N
    J Nephrol; 2006; 19(6):831-3. PubMed ID: 17173260
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Wilson's disease: long-term follow-up of a cohort of 24 patients treated with D-penicillamine.
    Lowette KF; Desmet K; Witters P; Laleman W; Verslype C; Nevens F; Fevery J; Cassiman DM
    Eur J Gastroenterol Hepatol; 2010 May; 22(5):564-71. PubMed ID: 20042865
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Combination treatment with penicillamine and trientine in a patient with Wilson's disease.
    Kobayashi S; Kodama H; Inuzuka R; Mori Y; Yanagawa Y
    Pediatr Int; 2005 Oct; 47(5):589-91. PubMed ID: 16190972
    [No Abstract]   [Full Text] [Related]  

  • 9. Penicillamine-induced lethal status dystonicus in a patient with Wilson's disease.
    Svetel M; Sternić N; Pejović S; Kostić VS
    Mov Disord; 2001 May; 16(3):568-9. PubMed ID: 11391761
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Wilson's disease.
    Walshe JM
    Lancet; 2007 Mar; 369(9565):902. PubMed ID: 17368141
    [No Abstract]   [Full Text] [Related]  

  • 11. Esophagobronchial fistula combined with a peptic esophageal stenosis.
    Klein M; Neubert U; Koop H
    Z Gastroenterol; 2000 Oct; 38(10):841-4. PubMed ID: 11089269
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Maintenance zinc therapy after initial penicillamine chelation to treat symptomatic hepatic Wilson's disease in resource constrained setting.
    Gupta P; Choksi M; Goel A; Zachariah U; Sajith KG; Ramachandran J; Chandy G; Kurian G; Rebekah G; Eapen CE
    Indian J Gastroenterol; 2018 Jan; 37(1):31-38. PubMed ID: 29457214
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Epileptic status immediately after initiation of D-penicillamine therapy in a patient with Wilson's disease.
    Berger B; Mader I; Damjanovic K; Niesen WD; Stich O
    Clin Neurol Neurosurg; 2014 Dec; 127():122-4. PubMed ID: 25459257
    [No Abstract]   [Full Text] [Related]  

  • 14. Pregnancy and penicillamine treatment in a patient with Wilson's disease.
    Morimoto I; Ninomiya H; Komatsu K; Satho M
    Jpn J Med; 1986 Feb; 25(1):59-62. PubMed ID: 3712863
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intestinal Behçet's disease with an esophageal ulcer.
    Kawabata H; Miyata M; Kawaguchi Y; Ueda M; Uno K; Tanaka K; Cho E; Yasuda K; Nakajima M
    Gastrointest Endosc; 2003 Jul; 58(1):151-4. PubMed ID: 12838248
    [No Abstract]   [Full Text] [Related]  

  • 16. Efficacy and safety of oral chelators in treatment of patients with Wilson disease.
    Weiss KH; Thurik F; Gotthardt DN; Schäfer M; Teufel U; Wiegand F; Merle U; Ferenci-Foerster D; Maieron A; Stauber R; Zoller H; Schmidt HH; Reuner U; Hefter H; Trocello JM; Houwen RH; Ferenci P; Stremmel W;
    Clin Gastroenterol Hepatol; 2013 Aug; 11(8):1028-35.e1-2. PubMed ID: 23542331
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bleeding oesophageal varices in patients with Wilson's disease.
    Sternlieb I; Scheinberg IH; Walshe JM
    Lancet; 1970 Mar; 1(7648):638-41. PubMed ID: 4190630
    [No Abstract]   [Full Text] [Related]  

  • 18. Measurement of urinary copper excretion after 48-h d-penicillamine cessation as a compliance assessment in Wilson's disease.
    Dzieżyc K; Litwin T; Chabik G; Członkowska A
    Funct Neurol; 2015; 30(4):264-8. PubMed ID: 26727705
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Late presentation of Wilson's disease].
    Santander Vaquero C
    Rev Esp Enferm Dig; 2002 Aug; 94(8):502-3. PubMed ID: 12486857
    [No Abstract]   [Full Text] [Related]  

  • 20. Hypothyroidism and dyshormonogenesis induced by D-penicillamine in children with Wilson's disease and healthy infants born to a mother with Wilson's disease.
    Hanukoglu A; Curiel B; Berkowitz D; Levine A; Sack J; Lorberboym M
    J Pediatr; 2008 Dec; 153(6):864-6. PubMed ID: 19014823
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.